Below are current clinical trials.5 studies in Lung Transplant Program
(open studies only).
Filter this list of studies by location, status and more.
The objective of this study is to obtain preliminary data to evaluate the accuracy of non-invasive blood pressure measurement in patients supported by continuous-flow left ventricular assist device (LVAD) using non-invasive supra-systolic methods in highly sensitive experimental blood pressure monitor.
The purpose of this study is to longitudinally follow Torque Teno Virus (TTV) levels in lung transplant recipients and attempt to find a correlation with infection or rejection events.
The purpose of this study is to:
- Demonstrate pharmacogenetic variability in the Mayo Clinic Florida lung transplant population.
- Describe patterns in tacrolimus levels in the context of pharmacogenomic profiles
- Use pharmacogenomic data to establish a need for therapeutic drug monitoring in selected other drugs
- Use pharmacogenomic data, in combination with knowledge of drug interactions, to establish sensitivity to tacrolimus dose changes
Jacksonville, Fla., Rochester, Minn.
The purpose of this study is to determine if DNA originating from the transplanted heart or lung can be detected in the blood and used to monitor for rejection.
To assess the safety and feasibility of mesenchymal stem cells therapy in patients with transplant related bronchiolitis obliteran syndrome (BOS).
March 09, 2019